Objective
Allogeneic hematopoietic stem cell transplantation (HSCT) is an increasingly used intensive therapy to treat patients with hematological malignancies and other life-threatening hematological and genetic diseases. Acute graft-versus-host disease (aGVHD) is the main complication of HSCT and an important cause of mortality. Cellular therapy with CD4+FOXP3+ regulatory T cells (Treg), a population with potent immunosuppressive properties, has proven highly effective in mouse models of GVHD; however, translation of this approach into humans has been difficult because of the identification of several distinct subsets of human Treg and the observation that an inflammatory environment may cause conversion of human Treg into effector T cells with pro-inflammatory functions. However, the notion of Treg cell plasticity remains highly controversial because of the heterogeneity of the Treg population and because clear evidence for lineage reprogramming is not available. The question whether Treg are a stable lineage is of paramount importance for the potential application of Treg therapy in the clinic.
The main goal of this project is to promote the fundamental knowledge of human Treg subpopulations and to define their role in preventing aGVHD. We will characterize the heterogeneity of the Treg compartment using an efficient and robust single-cell analysis pipeline. Since the lymphopenic environment and inflammation created by conditioning treatment prior to HSCT may favor Treg conversion, we will determine a potential plasticity of Treg subpopulations in cell-based assay systems and by studying chromatin modifications at the loci of lineage-specific transcription factors and cytokine genes. Furthermore, we will analyze the role of Treg subsets in aGVHD, to define potential correlations with disease severity and response to treatment. This approach may identify new biomarkers for early diagnosis and steroid-resistant GVHD.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- medical and health sciences medical biotechnology cells technologies stem cells
- medical and health sciences clinical medicine emergency medicine graft versus host disease
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP7-PEOPLE-2011-IEF
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
75724 Paris
France
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.